Search

everythinglearnresearchcommunity

for

Search:↓

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

Most hospitalized COVID-19 patients had long-term symptoms like fatigue and hair loss, with women and those sicker during hospitalization at higher risk.

Some drugs may reduce prostatitis symptoms short-term with few side effects.

Dermatologists are more accurate than general practitioners in diagnosing skin conditions, especially skin cancer.

HIV can cause various severe or unusual skin conditions that help indicate the presence and stage of the disease.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

Minoxidil needs activation to work, and minoxidil sulfate helps with hair growth and blood pressure.

Certain drugs that block specific enzymes can help treat prostate diseases.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Hair breakage may be an early sign of a hair loss condition called CCCA in African American women.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Men with Kennedy disease have less chance of hair loss.

New methods to make oxasteroids show promise for medical treatments like osteoporosis and breast cancer.

Finasteride may cause suicidal thoughts and mental side effects, especially in young people with hair loss.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

Scalp cooling is largely ineffective in preventing hair loss from breast cancer chemotherapy.

Microneedles help treat hair loss by improving hair surroundings and promoting growth.

Dutasteride more effectively treats hair loss than finasteride, but may increase risk of altered libido.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Higher BMI links to worse hair loss in Taiwanese men.

The study found that combining different databases gives a better estimate of drug side effects in hospitals.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

People with Major Depressive Disorder have a higher chance of getting Alopecia Areata, and vice versa; antidepressants may lower this risk.

Leflunomide and methotrexate are equally effective for rheumatoid arthritis but have different side effects.

Female hair loss linked to metabolic syndrome, not in males.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.